The new instrument enables high-throughput small and large molecule characterization in traditional and AI-driven workflows Salt Lake City, Utah – Carterra Inc., the world leader in innovative technologies enabling high-throughput biology, today has launched Carterra Ultra™—the latest addition to its LSA® and LSAXT label-free high-throughput surface plasmon resonance (HT-SPR) instruments. The Ultra platform enables small molecule applications […]
Christine Munz appointed as CEO Wilhelm Plüster completes term in office as planned Hamburg – The Supervisory Board of Eppendorf SE has appointed Dr. Christine Munz as the new CEO of the Eppendorf Group. On October 1, 2024, she will succeed Dr. Wilhelm Plüster who will now take on other strategically relevant responsibilities in the […]
Acquisition drives synergy within existing VION platform and creates greater opportunity to serve diagnostic market CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty materials in the life science research, diagnostic, and drug discovery spaces, announces its second acquisition this August with the acquisition of Ansh Labs, a biotechnology company that […]
Under a strategic partnership with Alamar Biosciences, Biognosys is a provider of choice of NULISA multiplex assay services for biopharma research The NULISAseq™ CNS Disease and Inflammation panels are now available for customers as a contract research service from Biognosys’ high-end proteomics facility in Europe By offering the combination of NULISA affinity-based assays and TrueDiscovery® mass […]
Thomas Unt, the CEO of SmiLe Inject Capital Lund, Sweden – SmiLe Inject Capital, an investment company under the SmiLe Venture Hub umbrella, is investing a total of 9 million SEK (0,8 million euros) in three promising life science startups: Uman Sense, Nygen Analytics, and Aligned Bio. All three companies are members of SmiLe and […]
QUANTUM-SI ANNOUNCES NEW EXECUTIVE TEAM MEMBERS TO ACCELERATE THE EVOLUTION OF THE COMPANY INTO A LEADING PROTEOMIC TOOL PROVIDER Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Todd Bennett will join QSI as the Company’s new Chief Commercial Officer effective September 17, 2024, John Vieceli, Ph.D. has been named Chief Product Officer […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that Todd Bennett will join QSI as the Company’s new Chief Commercial Officer effective September 16, 2024, John Vieceli, Ph.D. has been named Chief Product Officer and Lindsay Thompson has been named Chief Human Resources Officer. “I am pleased to welcome Todd to QSI […]
Acquisition serves as second for VION as it expands platform offering and product line, moves closer to supporting drug manufacturing space CHARLOTTESVILLE, Va. — VION Biosciences, a life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, announced the recent acquisition of Salt Lake City-based Echelon Biosciences, […]
HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Jon DiVincenzo will join the company as President and Chief Operating Officer, effective September 9, 2024, replacing Andy Last, who is retiring. Mr. DiVincenzo joins Bio-Rad from Labcorp Holdings Inc., a […]
Genovis, a leading innovator in enzyme technology, today announced the successful divestment of its antibody business to Leinco Technologies Inc., a globally recognized developer of high-quality antibodies for research and diagnostics. This strategic move aligns with Genovis previously communicated focus on optimizing the core business operation and enhancing profitability. The divestment follows a strategic review […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
